Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „encorafenib“
Suchtreffer
Begriffe & Kennungen
Braftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In patients treated with encorafenib 300 mg in combina
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination In the population treated with encorafenib 300 mg in c
Eintrag öffnenBraftovi · 4.8 · Colorectal cancer Encorafenib and cetuximab combination The incidence of increased transaminases in patients t
Eintrag öffnenBraftovi · 4.8 · Dermatitis acneiform Melanoma and NSCLC Dermatitis acneiform was reported when encorafenib is used in combinat
Eintrag öffnenBraftovi · 4.8 · Encorafenib with cetuximab and FOLFOX combination In the pooled EC+FOLFOX population, diarrhoea was observed i
Eintrag öffnenBraftovi · 4.8 · Hypertension Hypertension was reported when encorafenib was used in combination with binimetinib in melanoma a
Eintrag öffnenBraftovi · 4.8 · In the pooled encorafenib 300 population, PPES was reported in 51.6% (112/217) of patients. Most events were m
Eintrag öffnenBraftovi · 4.8 · In the pooled encorafenib 300 population, cuSCC was reported in 7.4% (16/217) patients. For patients in the Ph
Eintrag öffnenBraftovi · 4.8 · In the pooled encorafenib 300 population, facial paresis was observed in 7.4% (16/217) of patients. Most event
Eintrag öffnenBraftovi · 4.8 · In the pooled encorafenib 300 population, photosensitivity was reported in 4.1% (9/217) of patients. All event
Eintrag öffnenBraftovi · 4.8 · In the pooled encorafenib 300 population, rash was reported in 43.3% (94/217) of patients. Most events were mi
Eintrag öffnenBraftovi · 4.8 · Left ventricular dysfunction LVD was reported when encorafenib is used in combination with binimetinib in mela
Eintrag öffnenBraftovi · 4.8 · New primary melanoma Melanoma In the pooled encorafenib 300 population, new primary melanoma events occurred i
Eintrag öffnenBraftovi · 4.8 · Table 5: Adverse reactions Frequenc Encorafenib Encorafenib Encorafenib 300 mg in Encorafenib y single agent 4
Eintrag öffnenBraftovi · 4.8 · The encorafenib single agent (300 mg orally once daily) safety profile is based on data from 217 patients with
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with binimetinib (45 mg orally twice daily
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with cetuximab (dosed as per its SmPC) was
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with cetuximab and FOLFOX was evaluated in
Eintrag öffnenBraftovi · 4.8 · The safety of encorafenib (450 mg orally once daily) in combination with binimetinib (45 mg orally twice daily
Eintrag öffnenBraftovi · 4.8 · Venous thromboembolism VTE was reported when encorafenib is used in combination with binimetinib in melanoma a
Eintrag öffnen